Virbac S.A.
VRBCF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1,397 | $1,247 | $1,216 | $1,064 |
| % Growth | 12.1% | 2.5% | 14.3% | – |
| Cost of Goods Sold | $460 | $437 | $421 | $351 |
| Gross Profit | $938 | $810 | $795 | $713 |
| % Margin | 67.1% | 64.9% | 65.4% | 67% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $203 |
| SG&A Expenses | $0 | $0 | $240 | $203 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $710 | $625 | $373 | $343 |
| Operating Expenses | $710 | $625 | $613 | $546 |
| Operating Income | $227 | $185 | $180 | $168 |
| % Margin | 16.3% | 14.8% | 14.8% | 15.8% |
| Other Income/Exp. Net | -$19 | -$10 | -$3 | -$9 |
| Pre-Tax Income | $208 | $175 | $177 | $159 |
| Tax Expense | $62 | $54 | $56 | $44 |
| Net Income | $145 | $121 | $122 | $113 |
| % Margin | 10.4% | 9.7% | 10% | 10.6% |
| EPS | 17.35 | 14.38 | 14.44 | 13.4 |
| % Growth | 20.7% | -0.4% | 7.8% | – |
| EPS Diluted | 17.34 | 14.38 | 14.43 | 13.4 |
| Weighted Avg Shares Out | 8 | 8 | 8 | 8 |
| Weighted Avg Shares Out Dil | 8 | 8 | 8 | 8 |
| Supplemental Information | – | – | – | – |
| Interest Income | $7 | $9 | $5 | $2 |
| Interest Expense | $12 | $9 | $4 | $6 |
| Depreciation & Amortization | $57 | $48 | $35 | $43 |
| EBITDA | $276 | $231 | $218 | $208 |
| % Margin | 19.8% | 18.5% | 18% | 19.6% |